Netherlands (NL)

Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives (2018) De Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, et al. Journal article rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al. Journal article Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? (2018) Merola E, Zandee W, De Mestier L, Klumpen HJ, Geboes KP, Poczkaj K, W DH, Munir A Conference contribution Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation (2018) Zundler S, Becker E, Spocinska M, Parga-Vidal L, Stark R, Atreya R, Rath T, et al. Conference contribution Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease (2018) Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, Van 'T Wout AB, Atreya R, et al. Journal article Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report (2018) Sahebi F, Garderet L, Kanate AS, Eikema DJ, Knelange NS, Alvelo OF, Koc Y, et al. Journal article NEW SYSTEMIC SCLEROSIS RISK LOCI IDENTIFIED THROUGH A META-GWAS STRATEGY (2018) Lopez-Isac E, Acosta-Herrera M, Assassi S, Simeon CP, Carreira PE, Castellvi I, Ortego-Centeno N, et al. Conference contribution A Phase IIa Study of Anti-GM-CSF Antibody GSK3196165 in Subjects with Inflammatory Hand Osteoarthritis (2018) Schett G, Bainbridge C, Berkowitz M, Davy K, Fernandes S, Griep E, Harrison S, et al. Conference contribution ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL (2018) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution